Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 4:01 PM ET

Date/Time Source News Release
11/25/2024 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference
11/12/2024 09:03 AM EST GlobeNewswire Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
09/24/2024 08:00 AM EDT GlobeNewswire Milestone Pharmaceuticals to Host Investor KOL Event
09/06/2024 07:00 AM EDT GlobeNewswire Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
09/04/2024 08:00 AM EDT GlobeNewswire Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
09/03/2024 08:00 AM EDT GlobeNewswire Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/26/2024 08:00 AM EDT GlobeNewswire Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
08/08/2024 04:17 PM EDT GlobeNewswire Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
07/31/2024 08:00 AM EDT GlobeNewswire Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
07/15/2024 08:00 AM EDT GlobeNewswire Milestone Pharmaceuticals Refreshes Board of Directors
Page

Additional News

As of January 3, 2025 • 4:01 PM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Milestone Pharmaceuticals Inc.
11/19/2024 09:55 AM EST Zacks After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
11/12/2024 05:09 PM EST SeekingAlpha Milestone Pharmaceuticals files for mixed shelf offering
11/12/2024 10:31 AM EST SeekingAlpha Milestone Pharmaceuticals GAAP EPS of -$0.14
08/22/2024 03:12 PM EDT SeekingAlpha Milestone wins Buy at Rodman & Renshaw on potential Cardamyst approval
08/09/2024 06:17 AM EDT SeekingAlpha Milestone Pharmaceuticals GAAP EPS of -$0.14
05/16/2024 12:00 PM EDT Zacks Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know
05/13/2024 08:42 AM EDT SeekingAlpha Milestone Pharmaceuticals GAAP EPS of -$0.21 beats by $0.05
05/10/2024 05:38 AM EDT US Earnings Reports Expected earnings - Milestone Pharmaceuticals Inc.
03/22/2024 05:36 AM EDT US Earnings Reports Expected earnings - Milestone Pharmaceuticals Inc.
Page